NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers
|
journal
|
January 2020 |
Molecular Biology of Breast Cancer
|
book
|
November 2016 |
Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies
|
journal
|
April 2019 |
Variant classification in precision oncology
|
journal
|
May 2019 |
Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria
|
journal
|
June 2019 |
Dynamic genome and transcriptional network‐based biomarkers and drugs: precision in breast cancer therapy
|
journal
|
November 2018 |
NTHL1 and MUTYH polyposis syndromes: two sides of the same coin?: Base excision repair polyposis syndromes
|
journal
|
December 2017 |
Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications: Prognostic features of metaplastic breast cancer
|
journal
|
December 2018 |
Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile
|
journal
|
August 2019 |
A genome-wide analysis of colorectal cancer in a child with Noonan syndrome
|
journal
|
July 2018 |
A Summary of the Biological Processes, Disease-Associated Changes, and Clinical Applications of DNA Methylation
|
book
|
December 2017 |
Identification of frequent somatic mutations in inflammatory breast cancer
|
journal
|
February 2017 |
Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11)
|
journal
|
August 2019 |
How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective
|
journal
|
June 2019 |
Two-phase SSU and SKAT in genetic association studies
|
journal
|
January 2020 |
Analysis of somatic microsatellite indels identifies driver events in human tumors
|
journal
|
September 2017 |
Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy
|
journal
|
August 2016 |
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
|
journal
|
August 2017 |
Bayesian inference of negative and positive selection in human cancers
|
journal
|
November 2017 |
Compromised BRCA1–PALB2 interaction is associated with breast cancer risk
|
journal
|
March 2017 |
Nucleostemin reveals a dichotomous nature of genome maintenance in mammary tumor progression
|
journal
|
January 2019 |
CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3
|
journal
|
February 2019 |
Mutational processes contributing to the development of multiple myeloma
|
journal
|
August 2019 |
Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers
|
journal
|
April 2018 |
The effects of mutational processes and selection on driver mutations across cancer types
|
journal
|
May 2018 |
Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants
|
journal
|
June 2018 |
Whole-genome sequencing reveals novel tandem-duplication hotspots and a prognostic mutational signature in gastric cancer
|
journal
|
May 2019 |
Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes
|
journal
|
July 2019 |
A practical guide for mutational signature analysis in hematological malignancies
|
journal
|
July 2019 |
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
|
journal
|
July 2019 |
Detailed modeling of positive selection improves detection of cancer driver genes
|
journal
|
July 2019 |
Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome
|
journal
|
October 2019 |
Structural basis for adhesion G protein-coupled receptor Gpr126 function
|
journal
|
January 2020 |
Intra-tumour diversification in colorectal cancer at the single-cell level
|
journal
|
April 2018 |
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
|
journal
|
April 2018 |
The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies
|
journal
|
September 2019 |
Identification of cancer driver genes based on nucleotide context
|
journal
|
February 2020 |
Contradictory mRNA and protein misexpression of EEF1A1 in ductal breast carcinoma due to cell cycle regulation and cellular stress
|
journal
|
September 2018 |
Higher prevalence of homologous recombination deficiency in tumors from African Americans versus European Americans
|
journal
|
January 2020 |
Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes
|
journal
|
April 2020 |
Leveraging premalignant biology for immune-based cancer prevention
|
journal
|
September 2016 |
The implication of the SUMOylation pathway in breast cancer pathogenesis and treatment
|
journal
|
January 2020 |
Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies
|
journal
|
January 2018 |
Modeling clinical and molecular covariates of mutational process activity in cancer
|
journal
|
July 2019 |
The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers
|
journal
|
February 2018 |
Modeling Breast Cancer Using CRISPR-Cas9–Mediated Engineering of Human Breast Organoids
|
journal
|
October 2019 |
Germline determinants of the somatic mutation landscape in 2,642 cancer genomes
|
posted_content
|
November 2017 |
Insights into the mutational burden of human induced pluripotent stem cells using an integrative omics approach
|
posted_content
|
June 2018 |
Modeling the MYC-driven normal-to-tumour switch in breast cancer
|
posted_content
|
August 2018 |
Universal cancer tasks, evolutionary tradeoffs, and the functions of driver mutations
|
posted_content
|
August 2018 |
A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures
|
journal
|
November 2019 |
An integrative ENCODE resource for cancer genomics
|
journal
|
July 2019 |
The circular RNome of primary breast cancer
|
journal
|
January 2019 |
Saving the spandrels? Adaptive genomic variation in conservation and fisheries management: saving the spandrels
|
journal
|
October 2016 |
Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer
|
journal
|
September 2017 |
Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features
|
journal
|
June 2019 |
Embryonal precursors of Wilms tumor
|
journal
|
December 2019 |
Rat models of 17β-estradiol-induced mammary cancer reveal novel insights into breast cancer etiology and prevention
|
journal
|
March 2018 |
Interchromosomal Translocations as a Means to Map Chromosome Territories in Breast Cancer
|
journal
|
January 2019 |
Identification of coding and non-coding mutational hotspots in cancer genomes
|
journal
|
January 2017 |
Functional SNP allele discovery (fSNPd): an approach to find highly penetrant, environmental-triggered genotypes underlying complex human phenotypes
|
journal
|
December 2017 |
CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer
|
journal
|
July 2017 |
Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis
|
journal
|
November 2018 |
Therapeutic landscape in mutational triple negative breast cancer
|
journal
|
July 2018 |
Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer
|
journal
|
June 2020 |
Depletion of somatic mutations in splicing-associated sequences in cancer genomes
|
journal
|
November 2017 |
Recurrent mutations at estrogen receptor binding sites alter chromatin topology and distal gene expression in breast cancer
|
journal
|
November 2018 |
Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents
|
journal
|
November 2019 |
Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas
|
journal
|
September 2018 |
Hidden Markov models lead to higher resolution maps of mutation signature activity in cancer
|
journal
|
July 2019 |
Correlation of gene expression and associated mutation profiles of APOBEC3A, APOBEC3B, REV1, UNG, and FHIT with chemosensitivity of cancer cell lines to drug treatment
|
journal
|
April 2018 |
BeWith: A Between-Within method to discover relationships between cancer modules via integrated analysis of mutual exclusivity, co-occurrence and functional interactions
|
journal
|
October 2017 |
Integrated structural variation and point mutation signatures in cancer genomes using correlated topic models
|
journal
|
February 2019 |
APOBEC3A is a prominent cytidine deaminase in breast cancer
|
journal
|
December 2019 |
Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients
|
journal
|
September 2018 |
Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial—Clinical outcomes and molecular determinants of response
|
journal
|
February 2019 |
Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia
|
journal
|
November 2019 |
High expression of the vacuole membrane protein 1 (VMP1) is a potential marker of poor prognosis in HER2 positive breast cancer
|
journal
|
August 2019 |
The challenges of modeling hormone receptor-positive breast cancer in mice
|
journal
|
May 2018 |
The Unfolded Protein Response in Breast Cancer
|
journal
|
September 2018 |
Targeting DNA Replication Stress for Cancer Therapy
|
journal
|
August 2016 |
The cJUN NH2-terminal kinase (JNK) signaling pathway promotes genome stability and prevents tumor initiation
|
journal
|
June 2018 |
Somatic mutations in early metazoan genes disrupt regulatory links between unicellular and multicellular genes in cancer
|
journal
|
February 2019 |
Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplification
|
journal
|
April 2020 |
Using gene expression data to direct breast cancer therapy: evidence from a preclinical trial
|
journal
|
January 2018 |
CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis
|
journal
|
July 2018 |
Human genomics projects and precision medicine
|
journal
|
August 2017 |
The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis
|
journal
|
September 2016 |
Hereditary breast and ovarian cancer: new genes in confined pathways
|
journal
|
August 2016 |
Chronic expression of wild-type Ret receptor in the mammary gland induces luminal tumors that are sensitive to Ret inhibition
|
journal
|
April 2018 |
BRCA1/2 testing: therapeutic implications for breast cancer management
|
journal
|
June 2018 |
Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes
|
journal
|
October 2017 |
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures
|
journal
|
April 2018 |
Subclonal mutation selection in mouse lymphomagenesis identifies known cancer loci and suggests novel candidates
|
journal
|
July 2018 |
Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
|
journal
|
December 2018 |
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer
|
journal
|
January 2019 |
Expression-based analyses indicate a central role for hypoxia in driving tumor plasticity through microenvironment remodeling and chromosomal instability
|
journal
|
October 2018 |
Breast cancer
|
journal
|
September 2019 |
Patterns of somatic structural variation in human cancer genomes
|
journal
|
February 2020 |
Integrative detection and analysis of structural variation in cancer genomes
|
journal
|
September 2018 |
Chromosome segregation errors generate a diverse spectrum of simple and complex genomic rearrangements
|
journal
|
March 2019 |
ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer
|
journal
|
January 2020 |
Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis
|
journal
|
July 2017 |
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
|
journal
|
June 2018 |
Co-regulated gene expression of splicing factors as drivers of cancer progression
|
journal
|
April 2019 |
Frequent mutation of the FOXA1 untranslated region in prostate cancer
|
journal
|
August 2018 |
Genome-wide mapping of regions preferentially targeted by the human DNA-cytosine deaminase APOBEC3A using uracil-DNA pulldown and sequencing
|
journal
|
October 2019 |
Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy
|
journal
|
June 2019 |
MALAT1 long non-coding RNA and breast cancer
|
journal
|
March 2019 |
The Sequence Alignment/Map format and SAMtools
|
journal
|
June 2009 |
WITER: a powerful method for estimation of cancer-driver genes using a weighted iterative regression modelling background mutation counts
|
journal
|
July 2019 |
Identification of cis-regulatory mutations generating de novo edges in personalized cancer gene regulatory networks
|
posted_content
|
April 2017 |
SURF: integrative analysis of a compendium of RNA-seq and CLIP-seq datasets highlights complex governing of alternative transcriptional regulation by RNA-binding proteins
|
posted_content
|
May 2020 |
Comprehensive Analysis of Indels in Whole-genome Microsatellite Regions and Microsatellite Instability across 21 Cancer Types
|
posted_content
|
February 2019 |
Signatures of replication timing, recombination and sex in the spectrum of rare variants on the human X chromosome and autosomes
|
posted_content
|
May 2019 |
Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations
|
journal
|
February 2017 |
Homologous Recombination and Replication Fork Protection: BRCA2 and More!
|
journal
|
January 2017 |
Aneuploidy and a deregulated DNA damage response suggest haploinsufficiency in breast tissues of BRCA2 mutation carriers
|
journal
|
January 2020 |
RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation
|
journal
|
August 2016 |
Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes
|
journal
|
February 2018 |
Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer
|
journal
|
April 2018 |
Press-pulse: a novel therapeutic strategy for the metabolic management of cancer
|
journal
|
February 2017 |
Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer
|
journal
|
December 2019 |
Prioritization and functional assessment of noncoding variants associated with complex diseases
|
journal
|
July 2018 |
In vivo models in breast cancer research: progress, challenges and future directions
|
journal
|
April 2017 |
Software for Computing and Annotating Genomic Ranges
|
journal
|
August 2013 |
The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer
|
journal
|
August 2016 |
Transcriptional regulation of normal human mammary cell heterogeneity and its perturbation in breast cancer
|
journal
|
January 2019 |
In situ CRISPR‐Cas9 base editing for the development of genetically engineered mouse models of breast cancer
|
journal
|
January 2020 |
Defects in homologous recombination repair behind the human diseases: FA and HBOC
|
journal
|
October 2016 |
The circular RNome of primary breast cancer.
|
text
|
January 2019 |
Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy.
|
text
|
January 2019 |
Non-coding RNAs underlie genetic predisposition to breast cancer
|
text
|
January 2020 |
Mutational signatures of ionizing radiation in second malignancies
|
text
|
January 2016 |
Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer
|
posted_content
|
June 2020 |
Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication
|
journal
|
December 2018 |
A sequential Monte Carlo algorithm for inference of subclonal structure in cancer
|
text
|
January 2019 |
Tumor suppressor MCPH1 regulates gene expression profiles related to malignant conversion and chromosomal assembly
|
journal
|
March 2019 |
MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB - NFIB fusion gene: MYB-NFIB -negative breast adenoid cystic carcinomas
|
journal
|
December 2017 |
Mechanisms of resistance to estrogen receptor modulators in ER+/HER2− advanced breast cancer
|
journal
|
August 2019 |
Histone methyltransferases regulate the transcriptional expression of ERα and the proliferation of tamoxifen-resistant breast cancer cells
|
journal
|
January 2020 |
Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?
|
journal
|
September 2016 |
Mechanism of tandem duplication formation in BRCA1-mutant cells
|
journal
|
November 2017 |
BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance
|
journal
|
December 2017 |
Defining driver mutations in the genomic landscape of breast cancer
|
journal
|
May 2016 |
Capicua restricts cancer stem cell-like properties in breast cancer cells
|
journal
|
February 2020 |
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma
|
journal
|
December 2019 |
The driver landscape of sporadic chordoma
|
journal
|
October 2017 |
Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis
|
journal
|
November 2017 |
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation
|
journal
|
April 2019 |
The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact
|
journal
|
November 2019 |
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
|
journal
|
February 2020 |
Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations
|
journal
|
August 2018 |
Transcriptomic response of breast cancer cells to anacardic acid
|
journal
|
May 2018 |
Challenges and future of precision medicine strategies for breast cancer based on a database on drug reactions
|
journal
|
September 2019 |
Breast tumour organoids: promising models for the genomic and functional characterisation of breast cancer
|
journal
|
January 2019 |
FusionPro, a Versatile Proteogenomic Tool for Identification of Novel Fusion Transcripts and Their Potential Translation Products in Cancer Cells
|
journal
|
June 2019 |
Olaparib for the treatment of breast cancer
|
journal
|
March 2018 |
The long noncoding RNA Malat1: Its physiological and pathophysiological functions
|
journal
|
October 2017 |
The whole-genome panorama of cancer drivers
|
posted_content
|
December 2017 |
Targeted mutation detection in breast cancer using MammaSeq™
|
journal
|
February 2018 |
Molecular features of premenopausal breast cancers in Latin American women: pilot results from the PRECAMA study
|
posted_content
|
August 2018 |
Comprehensive Genomic Characterization of Breast Tumors with BRCA1 and BRCA2 Mutations
|
journal
|
May 2019 |
Genomic aberration based molecular signatures efficiently characterize homologous recombination deficiency in prostate cancer
|
posted_content
|
June 2019 |
Novel patterns of complex structural variation revealed across thousands of cancer genome graphs
|
posted_content
|
November 2019 |
Whole‐exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breast
|
journal
|
October 2019 |
Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine
|
journal
|
January 2017 |
Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer
|
journal
|
December 2018 |
Pan-cancer analysis reveals technical artifacts in TCGA germline variant calls
|
journal
|
June 2017 |
Portrait of a cancer: mutational signature analyses for cancer diagnostics
|
journal
|
May 2019 |
New generation breast cancer cell lines developed from patient-derived xenografts
|
journal
|
June 2020 |
Structural rearrangements generate cell-specific, gene-independent CRISPR-Cas9 loss of fitness effects
|
journal
|
February 2019 |
Comprehensive pharmacogenomic characterization of gastric cancer
|
journal
|
February 2020 |
Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer
|
journal
|
June 2018 |
Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer
|
journal
|
April 2019 |
Association analysis identifies 65 new breast cancer risk loci
|
text
|
January 2017 |
Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants.
|
text
|
January 2018 |
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo.
|
text
|
January 2017 |
Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome.
|
text
|
January 2019 |
The repertoire of mutational signatures in human cancer
|
text
|
January 2020 |
Pan-cancer analysis of whole genomes.
|
text
|
January 2020 |
Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma
|
text
|
January 2021 |
Therapeutic Targeting of the IGF Axis
|
journal
|
August 2019 |
PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers
|
journal
|
March 2019 |
Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma
|
journal
|
April 2019 |
Perturbation of base excision repair sensitizes breast cancer cells to APOBEC3 deaminase-mediated mutations
|
journal
|
January 2020 |
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
|
journal
|
August 2019 |
The anaphase‐promoting complex: A key mitotic regulator associated with somatic mutations occurring in cancer
|
journal
|
October 2019 |
Prevalence of BRCA1 and BRCA2 gene mutations in Chinese patients with high‐risk breast cancer
|
journal
|
April 2019 |
Targeting DNA repair: the genome as a potential biomarker: Predictive genomic biomarkers in cancer
|
journal
|
February 2018 |
Recent advances in breast cancer research impacting clinical diagnostic practice
|
journal
|
January 2019 |
Constrained De Novo Sequencing of neo-Epitope Peptides Using Tandem Mass Spectrometry
|
book
|
January 2018 |
Mutant p53 in breast cancer: potential as a therapeutic target and biomarker
|
journal
|
March 2018 |
FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment
|
journal
|
April 2018 |
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
|
journal
|
August 2017 |
Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients
|
journal
|
May 2018 |
Genomic patterns of progression in smoldering multiple myeloma
|
journal
|
August 2018 |
The therapeutic significance of mutational signatures from DNA repair deficiency in cancer
|
journal
|
August 2018 |
A unified haplotype-based method for accurate and comprehensive variant calling
|
journal
|
March 2021 |
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
|
journal
|
November 2019 |
Signatures of positive selection reveal a universal role of chromatin modifiers as cancer driver genes
|
journal
|
October 2017 |
The Ras-related gene ERAS is involved in human and murine breast cancer
|
journal
|
August 2018 |
The canonical non-homologous end joining factor XLF promotes chromosomal deletion rearrangements in human cells
|
journal
|
January 2020 |
The evolving role of receptors as predictive biomarkers for metastatic breast cancer
|
journal
|
December 2018 |
Journey’s end: the quest for BRCA-like hereditary breast cancer genes is nearly over
|
journal
|
May 2019 |
Discovering novel mutation signatures by latent Dirichlet allocation with variational Bayes inference
|
journal
|
April 2019 |
Germline microsatellite genotypes differentiate children with medulloblastoma
|
journal
|
September 2019 |
APOBEC3A/B-induced mutagenesis is responsible for 20% of heritable mutations in the TpCpW context
|
posted_content
|
May 2016 |
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
|
journal
|
October 2019 |
Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing
|
journal
|
April 2018 |
A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling
|
journal
|
January 2019 |
Comprehensive evaluation of structural variation detection algorithms for whole genome sequencing
|
journal
|
June 2019 |
SURF: integrative analysis of a compendium of RNA-seq and CLIP-seq datasets highlights complex governing of alternative transcriptional regulation by RNA-binding proteins
|
journal
|
June 2020 |
Modelling the MYC-driven normal-to-tumour switch in breast cancer
|
journal
|
July 2019 |
Breaking point: the genesis and impact of structural variation in tumours
|
journal
|
January 2018 |
De novo mutational signature discovery in tumor genomes using SparseSignatures
|
journal
|
June 2021 |
Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers
|
journal
|
April 2018 |
Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era
|
journal
|
January 2019 |
Computational approaches for discovery of mutational signatures in cancer.
|
text
|
January 2019 |
Validating the concept of mutational signatures with isogenic cell models.
|
text
|
January 2018 |
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration.
|
text
|
January 2016 |
Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma
|
text
|
January 2021 |
GDNF and the RET Receptor in Cancer: New Insights and Therapeutic Potential
|
journal
|
January 2019 |
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
|
journal
|
October 2019 |
Identifying Biomarkers to Pair with Targeting Treatments within Triple Negative Breast Cancer for Improved Patient Stratification
|
journal
|
November 2019 |
Co-transcriptional R-loops are the main cause of estrogen-induced DNA damage
|
journal
|
August 2016 |
ascatNgs: Identifying Somatically Acquired Copy-Number Alterations from Whole-Genome Sequencing Data: ascatNgs: Identifying Copy-number Alterations from Sequencing Data
|
journal
|
December 2016 |
Emerging Role of Genomics and Cell-Free DNA in Breast Cancer
|
journal
|
June 2019 |
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration
|
journal
|
September 2016 |
Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations
|
journal
|
March 2018 |
Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
|
journal
|
July 2020 |
Fibroblast growth factor receptors as treatment targets in clinical oncology
|
journal
|
October 2018 |
The repertoire of mutational signatures in human cancer
|
journal
|
February 2020 |
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
|
journal
|
January 2020 |
In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data
|
journal
|
June 2019 |
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
|
journal
|
August 2019 |
Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction
|
journal
|
August 2017 |
NEAT1-containing paraspeckles: Central hubs in stress response and tumor formation
|
journal
|
October 2016 |
Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology
|
journal
|
December 2017 |
Insights into BRCA Cancer Predisposition from Integrated Germline and Somatic Analyses in 7632 Cancers
|
journal
|
April 2019 |
An Integrative Framework for Detecting Structural Variations in Cancer Genomes
|
posted_content
|
March 2017 |
Candidate cancer driver mutations in superenhancers and long-range chromatin interaction networks
|
journal
|
December 2017 |
Integrated single-nucleotide and structural variation signatures of DNA-repair deficient human cancers
|
posted_content
|
February 2018 |
Learning mutational signatures and their multidimensional genomic properties with TensorSignatures
|
posted_content
|
June 2020 |
Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study
|
journal
|
April 2019 |
Relation between DNA ionization potentials, single base substitutions and pathogenic variants
|
journal
|
July 2019 |
Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations
|
journal
|
June 2019 |
Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families
|
journal
|
April 2020 |
Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency
|
journal
|
June 2017 |
The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers.
|
text
|
January 2018 |
Homologous recombination DNA repair defects in PALB2-associated breast cancers.
|
text
|
January 2019 |
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.
|
text
|
January 2017 |
Butler enables rapid cloud-based analysis of thousands of human genomes.
|
text
|
January 2020 |
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
|
journalarticle
|
January 2020 |
A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases
|
journal
|
May 2019 |
Single peptides and combination modalities for triple negative breast cancer
|
journal
|
October 2019 |
Breast Cancer Heterogeneity: Roles in Tumorigenesis and Therapeutic Implications
|
journal
|
February 2017 |
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers
|
journal
|
January 2017 |
Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance
|
journal
|
November 2017 |
Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumors
|
journal
|
November 2018 |
Piercing the dark matter: bioinformatics of long-range sequencing and mapping
|
journal
|
March 2018 |
Detecting the mutational signature of homologous recombination deficiency in clinical samples
|
journal
|
April 2019 |
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
|
journal
|
September 2019 |
Effects of short indels on protein structure and function in human genomes
|
journal
|
August 2017 |
Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer
|
journal
|
February 2020 |
Cancer Target Gene Screening: a web application for breast cancer target gene screening using multi-omics data analysis
|
journal
|
January 2019 |
Detecting presence of mutational signatures in cancer with confidence
|
journal
|
September 2017 |
Hidden Markov Models Lead to Higher Resolution Maps of Mutation Signature Activity in Cancer
|
posted_content
|
August 2018 |
Epigenetic dysregulation underpins tumorigenesis in a cutaneous tumor syndrome
|
posted_content
|
July 2019 |
Aneuploidy and deregulated DNA damage response define haploinsufficiency in breast tissues of BRCA2 mutation carriers
|
posted_content
|
August 2019 |
Characterizing the allele- and haplotype-specific copy number landscape of cancer genomes at single-cell resolution with CHISEL
|
journal
|
November 2019 |
Optical mapping reveals a higher level of genomic architecture of chained fusions in cancer
|
journal
|
April 2018 |
Coexisting genomic aberrations associated with lymph node metastasis in breast cancer
|
journal
|
April 2018 |
Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort
|
journal
|
September 2019 |
Chromatin interactome mapping at 139 independent breast cancer risk signals
|
journal
|
January 2020 |
The rate and spectrum of mosaic mutations during embryogenesis revealed by RNA sequencing of 49 tissues
|
journal
|
May 2020 |
Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer
|
journal
|
February 2017 |
A practical guide for mutational signature analysis in hematological malignancies
|
text
|
January 2019 |
Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome
|
text
|
January 2019 |
Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
|
text
|
January 2017 |
Pan-cancer analysis of whole genomes
|
text
|
January 2020 |
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas
|
text
|
January 2018 |
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
|
journal
|
February 2017 |
Tandem Duplications May Supply the Missing Genetic Alterations in Many Triple-Negative Breast and Gynecological Cancers
|
journal
|
August 2018 |
Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B
|
journal
|
December 2016 |
Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development
|
journal
|
February 2019 |
Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
|
journal
|
February 2019 |
Breast cancer quantitative proteome and proteogenomic landscape
|
journal
|
April 2019 |
Tumor diversity and the trade-off between universal cancer tasks
|
journal
|
November 2019 |
Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort
|
journal
|
February 2017 |
Unique metabolic traits identify CCPAP
|
journal
|
April 2019 |
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
|
journal
|
February 2020 |
Evaluation of site-specific homologous recombination activity of BRCA1 by direct quantitation of gene editing efficiency
|
journal
|
February 2019 |
Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors
|
journal
|
February 2017 |
Signatures of replication timing, recombination, and sex in the spectrum of rare variants on the human X chromosome and autosomes
|
journal
|
August 2019 |
Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma
|
journal
|
April 2017 |
Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers
|
journal
|
July 2019 |
The Landscape of Somatic Genetic Alterations in Breast Cancers from CHEK2 Germline Mutation Carriers
|
journal
|
April 2019 |
The BioGRID interaction database: 2017 update
|
journal
|
December 2016 |
Rev1 is a base excision repair enzyme with 5′-deoxyribose phosphate lyase activity
|
journal
|
September 2016 |
Short inverted repeats contribute to localized mutability in human somatic cells
|
journal
|
August 2017 |
Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures
|
journal
|
May 2018 |
Expression-based analyses indicate a central role for hypoxia in driving tumor plasticity through microenvironment remodeling and chromosomal instability
|
journal
|
May 2018 |
BATCAVE: Calling somatic mutations with a tumor- and site-specific prior
|
posted_content
|
October 2019 |
The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer
|
journal
|
October 2016 |
CoMutPlotter: a web tool for visual summary of mutations in cancer cohorts
|
journal
|
July 2019 |
Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity
|
journal
|
September 2016 |
Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers.
|
journalarticle
|
January 2018 |
Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study
|
journal
|
October 2016 |
The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles
|
journal
|
November 2017 |
Somatic mutations in early onset luminal breast cancer
|
journal
|
April 2018 |
Prediction of circRNAs Based on the DNA Methylation-Mediated Feature Sponge Function in Breast Cancer
|
journal
|
June 2019 |
Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer
|
journal
|
May 2017 |
‘Omics Approaches to Explore the Breast Cancer Landscape
|
journal
|
January 2020 |
Computational Methods for Characterizing Cancer Mutational Heterogeneity
|
journal
|
June 2017 |
Integrative Transcriptomic Analysis Reveals a Multiphasic Epithelial–Mesenchymal Spectrum in Cancer and Non-tumorigenic Cells
|
journal
|
January 2020 |
CNV Detection from Circulating Tumor DNA in Late Stage Non-Small Cell Lung Cancer Patients
|
journal
|
November 2019 |
Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context
|
journal
|
January 2017 |
Diagnostic value of ultrasound combined with magnetic resonance imaging in different stages of breast cancer
|
journal
|
October 2018 |
BeWith: A Between-Within Method to Discover Relationships between Cancer Modules via Integrated Analysis of Mutual Exclusivity, Co-occurrence and Functional Interactions
|
text
|
January 2017 |